Viamet Pharmaceuticals Receives $3,000,100 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=988e0440-1ea8-46c4-b207-0a647f386e8c
Date
12/31/2012
Company Name
Viamet Pharmaceuticals
Mailing Address
4505 Emperor Blvd. Durham, NC 27703 USA
Company Description
Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
Website
http://www.viamet.com
Transaction Type
Venture Equity
Transaction Amount
$3,000,100
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor